Alpha DNA Investment Management’s BrightSpring Health Services BTSG Stock Holding History
Bought
Maintained
Sold
Other funds holding BTSG
KKRC
WBA
Alpha DNA Investment Management's BTSG Position: Q1 2025 in Review
Alpha DNA Investment Management sold out of BrightSpring Health Services (BTSG) in Q1 2025, closing a stake of 23,982 shares — an estimated $408K sold.
Alpha DNA Investment Management first reported a position in BTSG in Q4 2024 and held it in 1 quarter. The position peaked at $408K in Q4 2024. 163 funds tracked by Wall St. Rank hold BTSG as of Q1 2025.
- Alpha DNA Investment Management reported no remaining BrightSpring Health Services position as of Q1 2025 after selling out during the quarter.
- Alpha DNA Investment Management sold 23,982 BrightSpring Health Services shares in Q1 2025, an estimated $408K.
- Alpha DNA Investment Management first reported a position in BrightSpring Health Services in Q4 2024 and held it in 1 quarter.
- Alpha DNA Investment Management's BrightSpring Health Services position peaked at $408K in Q4 2024.
- 163 funds tracked by Wall St. Rank held BrightSpring Health Services as of Q1 2025.
Based on Alpha DNA Investment Management's 13F filing for Q1 2025, filed 19 May 2025.